Related Experiment Video
Updated: Aug 4, 2026

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety
Published on: July 24, 2011
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates
H D Strickler1, P S Rosenberg, S S Devesa
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Md 20852, USA.
Context:
Poliovirus vaccine contaminated with live simian virus 40 (SV40), a macaque polyomavirus that is tumorigenic in rodents, was used extensively in the United States between 1955 and 1963. Simian virus 40 DNA has recently been detected in several rare human tumors, including ependymomas, osteosarcomas, and mesotheliomas.
Objective:
To determine the risk of ependymoma, osteosarcoma, and mesothelioma among Americans who as children received SV40-contaminated poliovirus vaccine.
Design:
Retrospective cohort study using data from the Surveillance, Epidemiology, and End Results program (1973-1993) and the Connecticut Tumor Registry (1950-1969), as well as national mortality statistics (1947-1973).
Setting:
United States.
Participants:
Birth cohorts that were likely to have received SV40-contaminated poliovirus vaccine as infants, born 1956 through 1962 (60 811730 person-years of observation); as children, born 1947 through 1952 (46430953 person-years); or that were unexposed, born 1964 through 1969 (44959979 person-years).
Main Outcome Measures:
Relative risk (RR) of each cancer among exposed compared with unexposed birth cohorts.
Results:
Age-specific cancer rates were generally low and were not significantly elevated in birth cohorts exposed to SV40-contaminated vaccine. Specifically, compared with the unexposed, the relative risk of ependymoma was not increased in the cohorts exposed as infants (RR, 1.06; 95% confidence interval [CI], 0.69-1.63), or as children (RR, 0.98; 95% CI, 0.57-1.69) nor did the exposed have an increased risk of all brain cancers. Osteosarcoma incidence also showed no relation to exposure as infants (RR, 0.87; 95% CI, 0.71-1.06) or children (RR, 0.85; 95% CI, 0.59-1.22). Last, mesotheliomas were not significantly associated with exposure, although the cohorts studied have not yet reached the age at which these tumors tend to occur.
Conclusions:
After more than 30 years of follow-up, exposure to SV40-contaminated poliovirus vaccine was not associated with significantly increased rates of ependymomas and other brain cancers, osteosarcomas, or mesotheliomas in the United States.
Insights
Exposure to simian virus 40 (SV40)-contaminated poliovirus vaccine did not increase cancer risk. This study found no significant association between SV40 exposure and ependymomas, osteosarcomas, or mesotheliomas over 30 years later.
Area of Science:
- Oncology
- Virology
- Epidemiology
Background:
- Poliovirus vaccine administered between 1955-1963 contained simian virus 40 (SV40), a polyomavirus found in rare human tumors.
- SV40 DNA has been detected in human ependymomas, osteosarcomas, and mesotheliomas.
Purpose of the Study:
- To investigate the risk of ependymoma, osteosarcoma, and mesothelioma in individuals exposed to SV40-contaminated poliovirus vaccine during childhood.
- To determine long-term cancer risks associated with SV40 exposure.
Main Methods:
- Retrospective cohort study utilizing data from the Surveillance, Epidemiology, and End Results program and the Connecticut Tumor Registry.
- Analysis of birth cohorts exposed to SV40-contaminated poliovirus vaccine (1947-1969) compared to unexposed cohorts (1964-1969).
- Calculation of relative risk (RR) for specific cancers in exposed versus unexposed groups.
Main Results:
- No significant elevation in ependymoma or other brain cancer rates was observed in SV40-exposed cohorts (RR, 1.06; 95% CI, 0.69-1.63 for infants; RR, 0.98; 95% CI, 0.57-1.69 for children).
- Osteosarcoma incidence showed no association with SV40 exposure (RR, 0.87; 95% CI, 0.71-1.06 for infants; RR, 0.85; 95% CI, 0.59-1.22 for children).
- Mesothelioma association was not statistically significant, though study cohorts have not yet reached peak incidence age.
Conclusions:
- Over 30 years post-exposure, SV40-contaminated poliovirus vaccine is not linked to increased rates of ependymomas, other brain cancers, osteosarcomas, or mesotheliomas in the US.
- The study provides reassurance regarding the long-term safety of individuals exposed to SV40-contaminated vaccines.
Related Concept Videos
Viral Recombination
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Poliomyelitis

